Deal history
30 participations| Date | Company | Round | Raised | Post-money | Role |
|---|---|---|---|---|---|
| Sep 2026 | Enveda | Series E | ▮ | ▮ | ▮ |
| Sep 2026 | David Protein | Series B | ▮ | ▮ | ▮ |
| Aug 2026 | Whatnot | Series G | ▮ | ▮ | ▮ |
+ 27 more deals · all 30, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
Investment activity
ICONIQ Capital joined 21 recorded rounds in the last two years (9 in the last 12 months), up from 6 in the two years before. By year: 9 in 2026, 11 in 2025 and 6 in 2024. Across all 30 recorded rounds, 21 were later-stage, 6 were early-stage and 1 were secondary. ICONIQ Capital is recorded as lead on 1 of them. 3 rounds landed in the last 90 days. ICONIQ Capital most often invests alongside Alkeon Capital Management (4 shared rounds), Baillie Gifford (3 shared rounds) and Bessemer Venture Partners (3 shared rounds). Most recently: Enveda (Series E, Sep 2026) and David Protein (Series B, Sep 2026).
- ·The top 10 names in the book — of 27 recorded positions
- ·The 10 latest deals — of 30 rounds
- ·Watchlist + alerts for ICONIQ Capital's activity